WEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI) last week filed a legal complaint in the Chester County Court of Common Pleas against Dr. Xiaoyuan (Shawn) Chen, a former consultant, ...
WEST CHESTER, Pa., June 10, 2026--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI), a clinical-stage radiopharmaceutical company developing next-generation albumin-binding targeted ...
WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI) announced promising results from a 1-year follow-up on EBTATE (2 cycles, 3.7 GBq/cycle) treatment of ...
WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc. (MTTI), a clinical-stage company accelerating the development and global access of life-changing radiopharmaceuticals, ...
Hosted on MSN
MTTI Appoints Veteran Radiopharmaceutical Leader Dr. Danielle Meyrick as Chief Medical Officer
WEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI) has named Dr. Danielle Meyrick as its new Chief Medical Officer, strengthening its leadership team as it pushes forward with the ...
WEST CHESTER, Pa. & ISTANBUL — Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) today announced their agreement with Molecular Targeting Technologies, Inc. (MTTI), a clinical stage biotech company ...
The Michigan Tech Transportation Institute (MTTI) will provide the operating structure, resources, recognition, and leadership, in a collaborative environment, that supports research, education, and ...
The Michigan Tech Transportation Institute (MTTI) is allocated Internal Research and Development (IRAD) funding proportional to the indirect cost (IDC) recovery of MTTI Activities. These funds are ...
MTTI Highlights Clinical Experience in 81 GEP-NETs Patients and Differentiated Profile of Next-Generation PRRT Candidate EBTATE Following Presentation at SNMMI 2026 Molecular Targeting Technologies, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results